A Critical Review of Biological Properties, Delivery Systems and Analytical/Bioanalytical Methods for Determination of Bevacizumab. [electronic resource]
Producer: 20210914Description: 445-453 p. digitalISSN:- 1547-6510
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Bevacizumab -- administration & dosage
- Drug Delivery Systems
- Humans
- Phosphorylation
- Reproducibility of Results
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vascular Endothelial Growth Factor Receptor-1 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.